Kei Asukai

Clinical implications of the serum CA19-9 level in “biological borderline resectability” and “biological downstaging” in the setting of preoperative chemoradiation therapy for pancreatic cancer

Hidenori Takahashi, Daisaku Yamada, Kei Asukai et al. · Pancreatology · 2020 · 58 citations

Clinical Implications, Pancreatic Cancer, Gastrointestinal Oncology +7

The utility of nutritional supportive care with an eicosapentaenoic acid (EPA)-enriched nutrition agent during pre-operative chemoradiotherapy for pancreatic cancer: Prospective randomized control study

Hirofumi Akita, Hidenori Takahashi, Kei Asukai et al. · Clinical Nutrition ESPEN · 2019 · 52 citations

Nutrition, Pancreatic Cancer, Health Sciences +10

Prognostic Significance of Sarcopenia and Systemic Inflammatory Response in Patients With Esophageal Cancer

Tomoyuki Matsunaga, Hiroshi Miyata, Keijiro Sugimura et al. · Anticancer Research · 2018 · 51 citations

Poly(ethylene glycol)–poly(lysine) block copolymer–ubenimex conjugate targets aminopeptidase N and exerts an antitumor effect in hepatocellular carcinoma stem cells

Reishi Toshiyama, Masamitsu Konno, Hidetoshi Eguchi et al. · Oncogene · 2018 · 45 citations

Tumor Biology, Ethylene Glycol, Drug Targeting +10

Micro-RNA-130a-3p Regulates Gemcitabine Resistance via PPARG in Cholangiocarcinoma

Kei Asukai, Koichi Kawamoto, Hidetoshi Eguchi et al. · Annals of Surgical Oncology · 2017 · 42 citations

Medicine, Biliary Cancer, Cancer Cell Biology +5